Target intelligence / Profile preview

Parasite tubulin (microtubule polymerization)

Molecular classification
Enzyme, Cytoskeletal protein, Other
01

Overview

Parasite microtubule polymerization involves the assembly of microtubules from tubulin subunits, which is essential for parasite cell division, structural integrity, motility, and host cell invasion[2][5][7]. Apicomplexan and kinetoplastid parasites exhibit unique structural architectures that differentiate their microtubules from those of mammals, such as hyper-stable subpellicular arrays and specialized invasion structures (like the conoid in Toxoplasma and Plasmodium)[5][7]. Several drug classes, including benzimidazoles, dinitroanilines, and newly designed agents like parabulin, can selectively target parasite microtubule polymerization, inhibiting parasite replication and infection while sparing host cells[6][4][8]. Selectivity arises from amino acid differences in the drug-binding sites of parasite tubulin, which enable structure-guided drug design[2][4][8]. This therapeutic avenue is threatened by the rapid emergence of drug-resistant parasite strains, making combination therapies and structural-guided drug development paramount[4][6].

Other names
Parasite tubulinparasite microtubuleprotozoan microtubuleapicomplexan microtubulekinetoplastid microtubule
02

Mechanism of action

Inhibition of tubulin polymerization, disrupting microtubule assembly and function. Selective binding to parasite tubulin to block microtubule resealing or cause destabilization. Inhibition of cell division by interfering with spindle formation during mitosis.

03

Biological functions

Cell divisionCell shape maintenanceMotilityHost cell invasionIntracellular transport
04

Disease associations

Infection (malaria, toxoplasmosis, trypanosomiasis, leishmaniasis)
05

Safety considerations

Potential off-target effects on host tubulin (although parasite tubulin has differences that can be selectively targeted[2][4][8])Drug resistance (parasites can acquire mutations that reduce drug efficacy)[4][6]Poor oral bioavailability of some agents (e.g., benzimidazoles)[6]
06

Interacting drugs

Benzimidazoles

4 more in the full profile.

07

Biomarkers

Parasite tubulin expression (immunodetection)Resistance mutations in parasite β-tubulin genes

Beyond the preview

Go deeper on Parasite tubulin (microtubule polymerization).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parasite tubulin (microtubule polymerization).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call